Found: 22
Select item for more details and to access through your institution.
Cutaneous Metastasis from Colorectal Cancer: Making Light on an Unusual and Misdiagnosed Event.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 9, p. 954, doi. 10.3390/life11090954
- By:
- Publication type:
- Article
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221096878
- By:
- Publication type:
- Article
Chronic Chest Pain Control after Trans-Thoracic Biopsy in Mediastinal Lymphomas.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 5, p. 589, doi. 10.3390/healthcare9050589
- By:
- Publication type:
- Article
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2117, doi. 10.3390/cancers15072117
- By:
- Publication type:
- Article
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4981, doi. 10.3390/cancers14204981
- By:
- Publication type:
- Article
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13 , 1941.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5715, doi. 10.3390/cancers13225715
- By:
- Publication type:
- Article
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1941, doi. 10.3390/cancers13081941
- By:
- Publication type:
- Article
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1504, doi. 10.3390/cancers11101504
- By:
- Publication type:
- Article
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 8, p. 1520, doi. 10.1002/ijc.34632
- By:
- Publication type:
- Article
Real‐world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 1, p. 133, doi. 10.1002/ijc.34462
- By:
- Publication type:
- Article
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 3, p. 473, doi. 10.1002/ijc.34033
- By:
- Publication type:
- Article
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 541, doi. 10.1007/s40261-024-01372-0
- By:
- Publication type:
- Article
All-in-One Spinal Cord Stimulation in Lymphoproliferative Diseases.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.550554
- By:
- Publication type:
- Article
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Temozolomide based treatment in glioblastoma: 6 vs. 12 months.
- Published in:
- Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14551
- By:
- Publication type:
- Article
Clinical activity of regorafenib in elderly patients with recurrent glioblastoma.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 2, p. N.PAG, doi. 10.3892/mco.2023.2605
- By:
- Publication type:
- Article
Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.813462
- By:
- Publication type:
- Article
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02332-2
- By:
- Publication type:
- Article